Arbor Research will work closely with the Centers for Disease Control and Prevention’s National Healthcare Safety Network to evaluate the ability of electronic health record (EHR) vendors to successfully implement and disseminate a standardized system for Clostridioides difficile infection (CDI) reporting into their EHR system, and assess the concordance of EHR versus manual-based reporting of CDIs by nursing homes.
Arbor Research will collaborate with prime contractor Lewin Group, as well as with the University of Michigan Kidney Epidemiology and Cost Center and ICF to assess the effectiveness of each model.
Study partnership will address disparities in hypertension control among racial and ethnic minority populations
Leader in broad-based finance and government contracting, Chauncey Lynch appointed to head Arbor Research finance team
Experienced business development professional Shanthy Edward, M.A., Psy.D. joins Arbor Research as Vice President of Strategic Growth & Chief Growth Officer.
Leaders in public health and social justice, Deborah Klein Walker, EdD, Med, BA and Gerald M. Croan, SB, MCP join Arbor Research’s Board of Directors
Seasoned business leader and researcher, Chris Spera, Ph.D, takes the helm at Arbor Research, succeeding retiring president, Robert M. Merion, M.D. FACS.
The Dialysis Outcomes and Practice Patterns (DOPPS) Program has expanded the DOPPS Practice Monitor (DPM) to include peritoneal dialysis (PD). The DPM-PD now reports the most up-to-date trends in care for patients receiving chronic PD in the US.
In a 1-year-old female patient with normal GGT cholestasis and bile duct paucity, we identified a homozygous truncating pathogenic variant (c.198delA, p.Gly67Alafs∗6) in the ABCC12 gene (NM_033226). Five additional rare ABCC12 variants, including a pathogenic one, were detected in our cohort.
Using data from the United States Renal Data System (USRDS), our researchers calculated access procedure (intervention) rates in the US for patients starting hemodialysis with an AVF or AVG created during their first year of hemodialysis therapy between July 1, 2012 and December 31, 2014 (N = 73,027).
